Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti
Clin Mol Hepatol 2018;24(2):151-162. Published online April 24, 2018
Background/Aims Correct renal function evaluation is based on estimated glomerular filtration rates (eGFR) and complementary renal damage biomarkers, such as neutrophil gelatinase associated lipocalin (NGAL). The aim of this study was to evaluate eGFR and NGAL modifications and renal impairment during treatment with a direct acting antiviral (DAA) for chronic hepatitis C virus (HCV) infection.
Methods A retrospective cohort study evaluated eGFR modification during treatment with DAA. Subgroup analysis on serum NGAL was conducted in those receiving sofosbuvir/ledipasvir, with complete follow-up until week 12 after the end of treatment (FU-12).
Results In the 102 enrolled patients, eGFR reduction was observed (from 86.22 mL/min at baseline to 84.43 mL/min at FU-12, P=0.049). Mean NGAL increased in 18 patients (from 121.89 ng/mL at baseline to 204.13 ng/mL at FU-12, P=0.014). At FU-12, 38.8% (7/18) of patients had a plasmatic NGAL value higher than the normal range (36-203 ng/mL) compared with 11.1% (2/18) at baseline (χ 2 =3,704; P=0.054). In contrast, eGFR did not change significantly over the follow-up in this subgroup.
Conclusions In conclusion, compared to a negligible eGFR decline observed in the entire cohort analyzed, a significant NGAL increase was observed after HCV treatment with DAA in a small subgroup. This could reflect tubular damage during DAA treatment rather than glomerular injury.
Citations
Citations to this article as recorded by
Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections Feng Chen, Shan-Shan Wu, Chao Chen, Cheng Zhou World Journal of Hepatology.2024; 16(2): 177. CrossRef
Evaluating short-term and long-term liver fibrosis improvement in hepatitis C patients after DAA treatment Yifan Wang, Xinyan Ma, Yanzheng Zou, Ming Yue, Meiling Zhang, Rongbin Yu, Hongbo Chen, Peng Huang The Journal of Biomedical Research.2024; 38(5): 464. CrossRef
Stem Cells in Kidney Ischemia: From Inflammation and Fibrosis to Renal Tissue Regeneration Rosario Cianci, Mariadelina Simeoni, Eleonora Cianci, Oriana De Marco, Antonio Pisani, Claudio Ferri, Antonietta Gigante International Journal of Molecular Sciences.2023; 24(5): 4631. CrossRef
Renal Stem Cells, Renal Resistive Index, and Neutrophil Gelatinase Associated
Lipocalin Changes After Revascularization in Patients With Renovascular Hypertension
and Ischemic Nephropathy Rosario Cianci, Mariadelina Simeoni, Antonietta Gigante, Adolfo Marco Perrotta, Sonia Ronchey, Nicola Mangialardi, Annalisa Schioppa, Oriana De Marco, Eleonora Cianci, Cristiana Barbati, Silvia Lai, Claudio Ferri Current Pharmaceutical Design.2023; 29(2): 133. CrossRef
Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed Rossella Di Paola, Ananya De, Anna Capasso, Sofia Giuliana, Roberta Ranieri, Carolina Ruosi, Antonella Sciarra, Caterina Vitagliano, Alessandra F. Perna, Giovambattista Capasso, Mariadelina Simeoni Journal of Personalized Medicine.2023; 13(5): 813. CrossRef
INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease Anil Arora, Ashish Kumar, Narayan Prasad, Ajay Duseja, Subrat K. Acharya, Sanjay K. Agarwal, Rakesh Aggarwal, Anil C. Anand, Anil K. Bhalla, Narendra S. Choudhary, Yogesh K. Chawla, Radha K. Dhiman, Vinod K. Dixit, Natarajan Gopalakrishnan, Ashwani Gupta, Journal of Clinical and Experimental Hepatology.2021; 11(3): 354. CrossRef
HCV cirrhotic patients treated with direct‐acting antivirals: Detection of tubular dysfunction and resolution after viral clearance Elisa Biliotti, Donatella Palazzo, Francesca Tinti, Maria Domenica D'Alessandro, Rozenn Esvan, Raffaella Labriola, Andrea Cappoli, Ilaria Umbro, Lorenzo Volpicelli, Alessandra Bachetoni, Erica Villa, Anna Paola Mitterhofer, Paola Rucci, Gloria Taliani Liver International.2021; 41(1): 158. CrossRef
Neutrophil gelatinase-associated lipocalin partly reflects the dynamic changes of renal function among chronic hepatitis C patients receiving direct-acting antivirals Yen-Chun Chen, Chen-Hao Li, Ping-Hung Ko, Chi-Che Lee, Ru-Jiang Syu, Chih-Wei Tseng, Kuo-Chih Tseng, Chen-Hua Liu PLOS ONE.2021; 16(8): e0256505. CrossRef
Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir Ali Nada, Mohamed Abbasy, Aliaa Sabry, Azza Mohamed Abdu Allah, Somaia Shehab-Eldeen, Nada Elnaidany, Hanan Elimam, Kawthar Ibraheem Mohamed Ibraheem, Abdallah Essa Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1. CrossRef
Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy) Vincenzo Scaglione, Maria Mazzitelli, Chiara Costa, Vincenzo Pisani, Giuseppe Greco, Francesca Serapide, Rosaria Lionello, Valentina La Gamba, Nadia Marascio, Enrico Maria Trecarichi, Carlo Torti Medicina.2020; 56(3): 101. CrossRef
Looking beyond Entecavir to discover Gitelman Syndrome in a 50 year-old man M Simeoni, V Columbano, Y Suzumoto, L Salviano, G Capolongo, M Zacchia, F Del Vecchio Blanco, A F Perna, V Nigro, G Capasso, F Trepiccione QJM: An International Journal of Medicine.2020; 113(10): 739. CrossRef
Hepatitis C virus and the kidney Stanislas Pol, Lucia Parlati, Michel Jadoul Nature Reviews Nephrology.2019; 15(2): 73. CrossRef
First
Prev
